Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis.
Saved in:
| Title: | Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis. |
|---|---|
| Authors: | Nash, Peter1 drpnash@tpg.com.au, Richette, Pascal2,3, Gossec, Laure4,5, Marchesoni, Antonio6, Ritchlin, Christopher7, Kato, Koji8, McDearmon-Blondell, Erin L8, Lesser, Elizabeth8, McCaskill, Reva8, Feng, Dai8, Anderson, Jaclyn K8, Ruderman, Eric M9 |
| Source: | Rheumatology. Aug2022, Vol. 61 Issue 8, p3257-3268. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14620324 |
|---|---|
| DOI: | 10.1093/rheumatology/keab905 |